Bausch Health Cos Total Liabilities 2012-2026 | BHC
Bausch Health Cos total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
Bausch Health Cos Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $25,989 |
| 2024 | $26,845 |
| 2023 | $27,432 |
| 2022 | $25,426 |
| 2021 | $29,236 |
| 2020 | $30,594 |
| 2019 | $32,727 |
| 2018 | $29,677 |
| 2017 | $31,553 |
| 2016 | $40,271 |
| 2015 | $42,936 |
| 2014 | $20,903 |
| 2013 | $22,738 |
| 2012 | $14,233 |
| 2011 | $9,178 |
|
Bausch Health Cos Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2026-06-30 | $25,596 |
| 2026-03-31 | $25,580 |
| 2025-12-31 | $25,989 |
| 2025-09-30 | $26,468 |
| 2025-06-30 | $27,119 |
| 2025-03-31 | $26,661 |
| 2024-12-31 | $26,845 |
| 2024-09-30 | $26,782 |
| 2024-06-30 | $26,722 |
| 2024-03-31 | $27,087 |
| 2023-12-31 | $27,432 |
| 2023-09-30 | $27,299 |
| 2023-06-30 | $25,232 |
| 2023-03-31 | $25,300 |
| 2022-12-31 | $25,426 |
| 2022-09-30 | $25,865 |
| 2022-06-30 | $27,918 |
| 2022-03-31 | $29,231 |
| 2021-12-31 | $29,236 |
| 2021-09-30 | $29,387 |
| 2021-06-30 | $30,653 |
| 2021-03-31 | $30,321 |
| 2020-12-31 | $30,594 |
| 2020-09-30 | $30,907 |
| 2020-06-30 | $30,850 |
| 2020-03-31 | $31,075 |
| 2019-12-31 | $32,727 |
| 2019-09-30 | $29,107 |
| 2019-06-30 | $29,666 |
| 2019-03-31 | $29,772 |
| 2018-12-31 | $29,677 |
| 2018-09-30 | $30,540 |
| 2018-06-30 | $30,890 |
| 2018-03-31 | $31,275 |
| 2017-12-31 | $31,553 |
| 2017-09-30 | $34,552 |
| 2017-06-30 | $37,704 |
| 2017-03-31 | $38,339 |
| 2016-12-31 | $40,271 |
| 2016-09-30 | $41,488 |
| 2016-06-30 | $42,259 |
| 2016-03-31 | $43,244 |
| 2015-12-31 | $42,936 |
| 2015-09-30 | $41,990 |
| 2015-06-30 | $41,785 |
| 2015-03-31 | $31,991 |
| 2014-12-31 | $20,903 |
| 2014-09-30 | $21,826 |
| 2014-06-30 | $22,528 |
| 2014-03-31 | $22,786 |
| 2013-12-31 | $22,738 |
| 2013-09-30 | $23,143 |
| 2013-06-30 | $14,080 |
| 2013-03-31 | $13,899 |
| 2012-12-31 | $14,233 |
| 2012-09-30 | $10,361 |
| 2012-06-30 | $10,324 |
| 2012-03-31 | $9,543 |
| 2011-12-31 | $9,178 |
| 2011-09-30 | $7,804 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |